High-mobility group AT-hook 2: An independent marker of poor prognosis in intrahepatic cholangiocarcinoma

Chung Ta Lee, Tsung Teh Wu, Christine M. Lohse, Lizhi Zhang

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

High-mobility group AT-hook 2 (HMGA2) regulates cell growth, differentiation, apoptosis, and neoplastic transformation. Previous studies have shown that malignant tumors expressing HMGA2, such as gastric, lung, and colorectal carcinomas, usually have a poor prognosis. HMGA2 expression and its clinical significance in intrahepatic cholangiocarcinomas have not been studied. We identified 55 intrahepatic cholangiocarcinomas resected at our institution from 1994 to 2003. Hematoxylin-eosin-stained slides were reviewed, and histopathologic characteristics were recorded, including mitotic count, tumor grade, vascular and perineural invasion, lymph node metastasis, and margin status. Using immunohistochemical stains, we examined expression of HMGA2, p53, p16, Kit, α-fetoprotein, and Ki-67, and we analyzed the correlation of survival with clinicopathological characteristics and immunohistochemical findings. Positive staining for HMGA2, p53, p16, Kit, α-fetoprotein, and Ki-67 was seen in 18 (33%), 37 (69%), 26 (47%), 21 (38%), 2 (4%), and 34 (63%) tumors, respectively. HMGA2 expression correlated positively with p53 expression (P =.02; ρ = 0.32) and negatively with p16 expression (P =.04; ρ = -0.28). Univariate analysis showed that HMGA2 expression and lymph node metastasis were associated with shorter patient survival and were independent indicators of poor survival (P =.02 and P =.03, respectively). Tumorigenic effects of HMGA2 in intrahepatic cholangiocarcinoma may partly reflect its ability to negatively regulate expression of p16 tumor suppressors and to be associated with p53 abnormalities.

Original languageEnglish (US)
Pages (from-to)2334-2340
Number of pages7
JournalHuman Pathology
Volume45
Issue number11
DOIs
StatePublished - Nov 1 2014

Fingerprint

AT-Hook Motifs
Cholangiocarcinoma
Fetal Proteins
Survival
Neoplasms
Lymph Nodes
Neoplasm Metastasis
Hematoxylin
Eosine Yellowish-(YS)
Blood Vessels
Cell Differentiation
Colorectal Neoplasms
Stomach
Coloring Agents
Apoptosis
Staining and Labeling

Keywords

  • HMGA2
  • IHC
  • Immunohistochemistry
  • Intrahepatic cholangiocarcinoma
  • p53
  • Prognosis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

High-mobility group AT-hook 2 : An independent marker of poor prognosis in intrahepatic cholangiocarcinoma. / Lee, Chung Ta; Wu, Tsung Teh; Lohse, Christine M.; Zhang, Lizhi.

In: Human Pathology, Vol. 45, No. 11, 01.11.2014, p. 2334-2340.

Research output: Contribution to journalArticle

Lee, Chung Ta ; Wu, Tsung Teh ; Lohse, Christine M. ; Zhang, Lizhi. / High-mobility group AT-hook 2 : An independent marker of poor prognosis in intrahepatic cholangiocarcinoma. In: Human Pathology. 2014 ; Vol. 45, No. 11. pp. 2334-2340.
@article{5a57139cc9484a0f857a53ae68b4774f,
title = "High-mobility group AT-hook 2: An independent marker of poor prognosis in intrahepatic cholangiocarcinoma",
abstract = "High-mobility group AT-hook 2 (HMGA2) regulates cell growth, differentiation, apoptosis, and neoplastic transformation. Previous studies have shown that malignant tumors expressing HMGA2, such as gastric, lung, and colorectal carcinomas, usually have a poor prognosis. HMGA2 expression and its clinical significance in intrahepatic cholangiocarcinomas have not been studied. We identified 55 intrahepatic cholangiocarcinomas resected at our institution from 1994 to 2003. Hematoxylin-eosin-stained slides were reviewed, and histopathologic characteristics were recorded, including mitotic count, tumor grade, vascular and perineural invasion, lymph node metastasis, and margin status. Using immunohistochemical stains, we examined expression of HMGA2, p53, p16, Kit, α-fetoprotein, and Ki-67, and we analyzed the correlation of survival with clinicopathological characteristics and immunohistochemical findings. Positive staining for HMGA2, p53, p16, Kit, α-fetoprotein, and Ki-67 was seen in 18 (33{\%}), 37 (69{\%}), 26 (47{\%}), 21 (38{\%}), 2 (4{\%}), and 34 (63{\%}) tumors, respectively. HMGA2 expression correlated positively with p53 expression (P =.02; ρ = 0.32) and negatively with p16 expression (P =.04; ρ = -0.28). Univariate analysis showed that HMGA2 expression and lymph node metastasis were associated with shorter patient survival and were independent indicators of poor survival (P =.02 and P =.03, respectively). Tumorigenic effects of HMGA2 in intrahepatic cholangiocarcinoma may partly reflect its ability to negatively regulate expression of p16 tumor suppressors and to be associated with p53 abnormalities.",
keywords = "HMGA2, IHC, Immunohistochemistry, Intrahepatic cholangiocarcinoma, p53, Prognosis",
author = "Lee, {Chung Ta} and Wu, {Tsung Teh} and Lohse, {Christine M.} and Lizhi Zhang",
year = "2014",
month = "11",
day = "1",
doi = "10.1016/j.humpath.2014.04.026",
language = "English (US)",
volume = "45",
pages = "2334--2340",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "11",

}

TY - JOUR

T1 - High-mobility group AT-hook 2

T2 - An independent marker of poor prognosis in intrahepatic cholangiocarcinoma

AU - Lee, Chung Ta

AU - Wu, Tsung Teh

AU - Lohse, Christine M.

AU - Zhang, Lizhi

PY - 2014/11/1

Y1 - 2014/11/1

N2 - High-mobility group AT-hook 2 (HMGA2) regulates cell growth, differentiation, apoptosis, and neoplastic transformation. Previous studies have shown that malignant tumors expressing HMGA2, such as gastric, lung, and colorectal carcinomas, usually have a poor prognosis. HMGA2 expression and its clinical significance in intrahepatic cholangiocarcinomas have not been studied. We identified 55 intrahepatic cholangiocarcinomas resected at our institution from 1994 to 2003. Hematoxylin-eosin-stained slides were reviewed, and histopathologic characteristics were recorded, including mitotic count, tumor grade, vascular and perineural invasion, lymph node metastasis, and margin status. Using immunohistochemical stains, we examined expression of HMGA2, p53, p16, Kit, α-fetoprotein, and Ki-67, and we analyzed the correlation of survival with clinicopathological characteristics and immunohistochemical findings. Positive staining for HMGA2, p53, p16, Kit, α-fetoprotein, and Ki-67 was seen in 18 (33%), 37 (69%), 26 (47%), 21 (38%), 2 (4%), and 34 (63%) tumors, respectively. HMGA2 expression correlated positively with p53 expression (P =.02; ρ = 0.32) and negatively with p16 expression (P =.04; ρ = -0.28). Univariate analysis showed that HMGA2 expression and lymph node metastasis were associated with shorter patient survival and were independent indicators of poor survival (P =.02 and P =.03, respectively). Tumorigenic effects of HMGA2 in intrahepatic cholangiocarcinoma may partly reflect its ability to negatively regulate expression of p16 tumor suppressors and to be associated with p53 abnormalities.

AB - High-mobility group AT-hook 2 (HMGA2) regulates cell growth, differentiation, apoptosis, and neoplastic transformation. Previous studies have shown that malignant tumors expressing HMGA2, such as gastric, lung, and colorectal carcinomas, usually have a poor prognosis. HMGA2 expression and its clinical significance in intrahepatic cholangiocarcinomas have not been studied. We identified 55 intrahepatic cholangiocarcinomas resected at our institution from 1994 to 2003. Hematoxylin-eosin-stained slides were reviewed, and histopathologic characteristics were recorded, including mitotic count, tumor grade, vascular and perineural invasion, lymph node metastasis, and margin status. Using immunohistochemical stains, we examined expression of HMGA2, p53, p16, Kit, α-fetoprotein, and Ki-67, and we analyzed the correlation of survival with clinicopathological characteristics and immunohistochemical findings. Positive staining for HMGA2, p53, p16, Kit, α-fetoprotein, and Ki-67 was seen in 18 (33%), 37 (69%), 26 (47%), 21 (38%), 2 (4%), and 34 (63%) tumors, respectively. HMGA2 expression correlated positively with p53 expression (P =.02; ρ = 0.32) and negatively with p16 expression (P =.04; ρ = -0.28). Univariate analysis showed that HMGA2 expression and lymph node metastasis were associated with shorter patient survival and were independent indicators of poor survival (P =.02 and P =.03, respectively). Tumorigenic effects of HMGA2 in intrahepatic cholangiocarcinoma may partly reflect its ability to negatively regulate expression of p16 tumor suppressors and to be associated with p53 abnormalities.

KW - HMGA2

KW - IHC

KW - Immunohistochemistry

KW - Intrahepatic cholangiocarcinoma

KW - p53

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=84908332737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908332737&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2014.04.026

DO - 10.1016/j.humpath.2014.04.026

M3 - Article

C2 - 25245603

AN - SCOPUS:84908332737

VL - 45

SP - 2334

EP - 2340

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 11

ER -